TrialPanorama/TrialPanorama-database huggingface dataset:
Study 35181666 — Predictive Biomarker (PRD): PIK3CA mRNA
Genes: PIK3CA
Study 35181666 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Cellular tumor antigen p53
Genes: TP53; P53
Study 35181666 — Monitoring Biomarker (MOI): Cell-free DNA
Study 35181700 — Safety Biomarker (SAF): von Willebrand factor
Genes: VWF; F8VWF
Study 35181700 — Predictive Biomarker (PRD): FABP4 mRNA
Genes: FABP4
Study 35182224 — Predictive Biomarker (PRD): Leukocyte surface antigen Leu-16
Genes: MS4A1; CD20
Study 35183442 — Predictive Biomarker (PRD): MSC mRNA
Genes: MSC; ABF1; BHLHA22
Study 35183775 — Predictive Biomarker (PRD): RET mRNA
Genes: RET; CDHF12; CDHR16; PTC; RET51
Study 35184142 — Surrogate Endpoint (SUR): Blood pressure
Study 35185912 — Predictive Biomarker (PRD); Safety Biomarker (SAF): CXCL1 mRNA
Genes: CXCL1; GRO; GRO1; GROA; MGSA; SCYB1
Study 35185912 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study 35185912 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study 35186305 — Surrogate Endpoint (SUR): Blood pressure
Study 35187168 — Predictive Biomarker (PRD): MAX mRNA
Genes: MAX; BHLHD4
Study 35187383 — Predictive Biomarker (PRD): LEAP2 mRNA
Genes: LEAP2
Study 35187396 — Pharmacodynamic Biomarker (PDY): Serum phosphate
Study 35187951 — Predictive Biomarker (PRD): Apoptosis regulator Bcl-2
Genes: BCL2
Study 35187951 — Predictive Biomarker (PRD): CDK4 mRNA
Genes: CDK4
Study 35187951 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study 35188608 — Safety Biomarker (SAF): Bacteroidetes phylum
Study 35189706 — Predictive Biomarker (PRD): SERPINA5 mRNA
Genes: SERPINA5; PCI; PLANH3; PROCI
Study 35189706 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 35190519 — Predictive Biomarker (PRD): NRAS mRNA
Genes: NRAS; HRAS1
Study 35190880 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Metalloproteinase inhibitor 1
Genes: TIMP1; CLGI; TIMP
Study 35191018 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Neutrophil gelatinase-associated lipocalin
Genes: LCN2; HNL; NGAL
Study 35191329 — Predictive Biomarker (PRD): FUT1 mRNA
Genes: FUT1; H; HSC
Study 35191428 — Predictive Biomarker (PRD): KLRK1 mRNA
Genes: KLRK1; D12S2489E; NKG2D
Study 35191428 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 35192550 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Free fatty acids
Study 35193705 — Predictive Biomarker (PRD): FES mRNA
Genes: FES; FPS
Study 35193932 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Tumor mutational burden
Study 35194110 — Predictive Biomarker (PRD); Safety Biomarker (SAF): miR-122
Genes: MIR122
Study 35194110 — Predictive Biomarker (PRD); Safety Biomarker (SAF): miR-34a
Genes: MIR34A
Study 35194110 — Safety Biomarker (SAF): miR-22
Genes: MIR22
Study 35194110 — Safety Biomarker (SAF): miR-1
Study 35194110 — Safety Biomarker (SAF): miR-375
Genes: MIR375
Study 35194596 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study 35194965 — Predictive Biomarker (PRD): CD63 mRNA
Genes: CD63; MLA1; TSPAN30
Study 35195533 — Predictive Biomarker (PRD): MIF mRNA
Genes: MIF; GLIF; MMIF
Study 35195837 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study 35195837 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 35195837 — Predictive Biomarker (PRD): ERBB4 mRNA
Genes: ERBB4; HER4
Study 35195881 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study 35196021 — Safety Biomarker (SAF): Interleukin 12
Study 35197359 — Pharmacodynamic Biomarker (PDY): Amyloid beta peptide (1-40)
Genes: APP; A4; AD1
Study 35198584 — Safety Biomarker (SAF): Cystatin C
Genes: CST3
Study 35198648 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 35198727 — Safety Biomarker (SAF): Clusterin
Genes: CLU; APOJ; CLI; KUB1; AAG4
Study 35199944 — Surrogate Endpoint (SUR): Blood pressure
Study 35200588 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 35200588 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 35200588 — Predictive Biomarker (PRD): Hormone receptor
Study 35201621 — Predictive Biomarker (PRD): Multidrug resistance protein 1
Genes: ABCB1; MDR1; PGY1
Study 35203321 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Osteopontin
Genes: SPP1; BNSP; OPN; PSEC0156
Study 35203547 — Surrogate Endpoint (SUR): Neutralizing antibody
Study 35204237 — Safety Biomarker (SAF): Interleukin 18
Genes: IL18; IGIF; IL1F4
Study 35204752 — Predictive Biomarker (PRD): CCN2 mRNA
Genes: CCN2; CTGF; HCS24; IGFBP8
Study 35204752 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study 35209871 — Predictive Biomarker (PRD): GEM mRNA
Genes: GEM; KIR
Study 35209952 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY): Microtubule-associated protein tau
Genes: MAPT; MAPTL; MTBT1; TAU
Study 35210075 — Safety Biomarker (SAF): B-type natriuretic peptide
Genes: NPPB
Study 35210262 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 35210326 — Predictive Biomarker (PRD): CD28 mRNA
Genes: CD28
Study 35210595 — Pharmacodynamic Biomarker (PDY): Gastric inhibitory polypeptide
Genes: GIP
Study 35210606 — Surrogate Endpoint (SUR): Neutralizing antibody
Study 35211079 — Predictive Biomarker (PRD): Tripeptidyl-peptidase I
Genes: TPP1; CLN2; GIG1; UNQ267/PRO304
Study 35211494 — Surrogate Endpoint (SUR): Serum creatinine
Study 35211517 — Predictive Biomarker (PRD): TCFL5 mRNA
Genes: TCFL5; CHA; E2BP1
Study 35211517 — Predictive Biomarker (PRD): KLHL17 mRNA
Genes: KLHL17; AF
Study 35211793 — Surrogate Endpoint (SUR): Serum creatinine
Study 35211796 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Metalloproteinase inhibitor 1
Genes: TIMP1; CLGI; TIMP
Study 35211796 — Predictive Biomarker (PRD): IGFBP7 mRNA
Genes: IGFBP7; MAC25; PSF
Study 35212486 — Predictive Biomarker (PRD): GLA
Genes: GALA
Study 35212906 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 35212906 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 35212906 — Predictive Biomarker (PRD): Hormone receptor
Study 35213039 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study 35213528 — Predictive Biomarker (PRD): CFH mRNA
Genes: CFH; HF; HF1; HF2
Study 35213528 — Pharmacodynamic Biomarker (PDY): Cholesteryl ester transfer protein
Genes: CETP
Study 35213713 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 35213713 — Surrogate Endpoint (SUR): Blood pressure
Study 35213769 — Predictive Biomarker (PRD): TTR mRNA
Genes: TTR; PALB
Study 35216589 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study 35217573 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Tumor mutational burden
Study 35217576 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Tumor mutational burden
Study 35217576 — Monitoring Biomarker (MOI): Cell-free DNA
Study 35217576 — Monitoring Biomarker (MOI): Circulating tumor DNA
Study 35221224 — Predictive Biomarker (PRD): PAH mRNA
Genes: PAH
Study 35222057 — Predictive Biomarker (PRD): ID1 mRNA
Genes: ID1; BHLHB24; ID
Study 35222077 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 35222077 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 35222077 — Predictive Biomarker (PRD): CS mRNA
Genes: CS
Study 35222077 — Surrogate Endpoint (SUR): Serum testosterone
Study 35222077 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 35222429 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 35222429 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study 35222719 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 35222735 — Predictive Biomarker (PRD): ASL mRNA
Genes: ASL
Study 35223458 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 35223458 — Predictive Biomarker (PRD): CDK4 mRNA
Genes: CDK4
Study 35223458 — Predictive Biomarker (PRD): CDK6 mRNA
Genes: CDK6; CDKN6
Study 35223458 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 35223458 — Predictive Biomarker (PRD): Hormone receptor
Study 35224732 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY): CCR2 mRNA
Genes: CCR2; CMKBR2
Study 35224730 — Surrogate Endpoint (SUR): Serum creatinine
Study 35226304 — Safety Biomarker (SAF): Cytochrome P450 2C19
Genes: CYP2C19
Study 35226304 — Predictive Biomarker (PRD): CYP2C9 mRNA
Genes: CYP2C9; CYP2C10
Study 35226732 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY): Microtubule-associated protein tau
Genes: MAPT; MAPTL; MTBT1; TAU
Study 35226739 — Predictive Biomarker (PRD): Leukocyte surface antigen Leu-16
Genes: MS4A1; CD20
Study 35226739 — Predictive Biomarker (PRD): CD38 mRNA
Genes: CD38
Study 35226999 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 35227313 — Surrogate Endpoint (SUR): Blood pressure
Study 35230254 — Surrogate Endpoint (SUR): Blood pressure
Study 35231037 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study 35232419 — Safety Biomarker (SAF): Interleukin 1
Study 35234826 — Predictive Biomarker (PRD): Laminin subunit alpha-3
Genes: LAMA3; LAMNA
Study 35234826 — Predictive Biomarker (PRD): LAMB3 mRNA
Genes: LAMB3; LAMNB1
Study 35234887 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 35234887 — Surrogate Endpoint (SUR): Blood pressure
Study 35235412 — Predictive Biomarker (PRD): Hormone receptor
Study 35235656 — Predictive Biomarker (PRD): CXADR mRNA
Genes: CXADR; CAR
Study 35235725 — Safety Biomarker (SAF): Cardiac troponin I
Genes: TNNI3; TNNC1
Study 35236331 — Predictive Biomarker (PRD): MYD88 mRNA
Genes: MYD88
Study 35236331 — Predictive Biomarker (PRD): CD79B mRNA
Genes: CD79B; B29; IGB
Study 35236331 — Predictive Biomarker (PRD): Apoptosis regulator Bcl-2
Genes: BCL2
Study 35236331 — Predictive Biomarker (PRD): EZH2 mRNA
Genes: EZH2; KMT6
Study 35236331 — Predictive Biomarker (PRD): NOTCH2 mRNA
Genes: NOTCH2
Study 35236342 — Predictive Biomarker (PRD): MMP12 mRNA
Genes: MMP12; HME
Study 35236342 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Metalloproteinase inhibitor 1
Genes: TIMP1; CLGI; TIMP
Study 35237748 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study 35238854 — Surrogate Endpoint (SUR): Serum creatinine
Study 35241101 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 35241101 — Surrogate Endpoint (SUR): Blood pressure
Study 35241119 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): D-dimer
Study 35241141 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 35241141 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 35241644 — Pharmacodynamic Biomarker (PDY): Huntingtin
Genes: HTT; HD; IT15
Study 35241844 — Surrogate Endpoint (SUR): Neutralizing antibody
Study 35242683 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 35242683 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study 35242798 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Monitoring Biomarker (MOI): Vitamin B12
Study 35243320 — Surrogate Endpoint (SUR): Neutralizing antibody
Study 35244520 — Predictive Biomarker (PRD): PAFAH1B1 mRNA
Genes: PAFAH1B1; LIS1; MDCR; MDS; PAFAHA
Study 35244681 — Predictive Biomarker (PRD): WT1 mRNA
Genes: WT1
Study 35244681 — Predictive Biomarker (PRD): PRAME mRNA
Genes: PRAME; MAPE; OIP4
Study 35245205 — Predictive Biomarker (PRD): PTPN11 mRNA
Genes: PTPN11; PTP2C; SHPTP2
Study 35245341 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Monitoring Biomarker (MOI): Vitamin B12
Study 35246452 — Surrogate Endpoint (SUR): Blood pressure
Study 35246457 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Complement C3
Genes: C3; CPAMD1
Study 35246776 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 35246776 — Predictive Biomarker (PRD): ARHGEF5 mRNA
Genes: ARHGEF5; TIM
Study 35247086 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study 35247086 — Predictive Biomarker (PRD): PDGFRB mRNA
Genes: PDGFRB; PDGFR; PDGFR1
Study 35247191 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): D-dimer
Study 35247923 — Predictive Biomarker (PRD); Safety Biomarker (SAF): CTNNB1 mRNA
Genes: CTNNB1; CTNNB; OK/SW-cl.35; PRO2286
Study 35248866 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study 35248866 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 35248866 — Predictive Biomarker (PRD): ERBB4 mRNA
Genes: ERBB4; HER4
Study 35249706 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 35249706 — Predictive Biomarker (PRD): TPR mRNA
Genes: TPR
Study 35250870 — Predictive Biomarker (PRD): SDS mRNA
Genes: SDS; SDH
Study 35251038 — Predictive Biomarker (PRD): Zinc finger protein GLI1
Genes: GLI1; GLI
Study 35251038 — Predictive Biomarker (PRD): GLI2 mRNA
Genes: GLI2; THP
Study 35251038 — Predictive Biomarker (PRD): KIT mRNA
Genes: KIT; SCFR
Study 35251320 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 35251320 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 35253361 — Predictive Biomarker (PRD): IL1RL1 mRNA
Genes: IL1RL1; DER4; ST2; T1
Study 35253361 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Angiopoietin-2
Genes: ANGPT2
Study 35253361 — Safety Biomarker (SAF): Plasminogen activator inhibitor
Genes: SERPINE1; PAI1; PLANH1
Study 35253450 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 35253450 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 35254385 — Predictive Biomarker (PRD): CDK4 mRNA
Genes: CDK4
Study 35254385 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 35254385 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study 35254385 — Predictive Biomarker (PRD): CCND1
Genes: U21B31
Study 35254415 — Safety Biomarker (SAF): PDCD1
Genes: CD279; PD1; hSLE1; PD-1
Study 35254416 — Predictive Biomarker (PRD): CD34 mRNA
Genes: CD34
Study 35255140 — Surrogate Endpoint (SUR): Neutralizing antibody
Study 35255964 — Predictive Biomarker (PRD): CD34 mRNA
Genes: CD34
Study 35255964 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 35255964 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 35255964 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 35256010 — Predictive Biomarker (PRD): LBP mRNA
Genes: LBP
Study 35256525 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 35256844 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study 35257579 — Predictive Biomarker (PRD): AAK1 mRNA
Genes: AAK1; KIAA1048
Study 35257949 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study 35257949 — Predictive Biomarker (PRD): Programmed cell death 1 ligand 1
Genes: CD274; B7H1; PDCD1L1; PDCD1LG1; PDL1
Study 35257949 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study 35258841 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 35258987 — Predictive Biomarker (PRD): O-6-methylguanine-DNA-alkyltransferase
Genes: MGMT
Study 35259629 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study 35260178 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY): Microtubule-associated protein tau
Genes: MAPT; MAPTL; MTBT1; TAU
Study 35260313 — Surrogate Endpoint (SUR): Blood pressure
Study 35260879 — Predictive Biomarker (PRD): LRRC15 mRNA
Genes: LRRC15; LIB
Study 35260913 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study 35260962 — Surrogate Endpoint (SUR): Blood pressure
Study 35263963 — Predictive Biomarker (PRD): JAK1
Genes: JAK1A; JTK3
Study 35264144 — Predictive Biomarker (PRD): HAS2 mRNA
Genes: HAS2
Study 35264144 — Predictive Biomarker (PRD): SHB mRNA
Genes: SHB
Study 35264144 — Predictive Biomarker (PRD): HBEGF mRNA
Genes: HBEGF; DTR; DTS; HEGFL
Study 35264144 — Predictive Biomarker (PRD): BMF mRNA
Genes: BMF
Study 35264400 — Predictive Biomarker (PRD): CD14 mRNA
Genes: CD14
Study 35264434 — Safety Biomarker (SAF): PDCD1
Genes: CD279; PD1; hSLE1; PD-1
Study 35264434 — Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): TNF related activation protein
Genes: CD40LG; CD40L; TNFSF5; TRAP
Study 35264434 — Predictive Biomarker (PRD): Programmed cell death 1 ligand 1
Genes: CD274; B7H1; PDCD1L1; PDCD1LG1; PDL1
Study 35264559 — Surrogate Endpoint (SUR): Neutralizing antibody
Study 35266046 — Predictive Biomarker (PRD): PEPD mRNA
Genes: PEPD; PRD
Study 35266132 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 35266132 — Monitoring Biomarker (MOI): Procalcitonin
Study 35266624 — Predictive Biomarker (PRD): GAD1 mRNA
Genes: GAD1; GAD; GAD67
Study 35266655 — Predictive Biomarker (PRD): Nerve growth factor
Genes: NGF; NGFB
Study 35266925 — Pharmacodynamic Biomarker (PDY): Fibroblast growth factor 23
Genes: FGF23; HYPF; UNQ3027/PRO9828
Study 35268280 — Predictive Biomarker (PRD): CSF1R mRNA
Genes: CSF1R; FMS
Study 35272846 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study 35272946 — Predictive Biomarker (PRD): PIK3CA mRNA
Genes: PIK3CA
Study 35272946 — Predictive Biomarker (PRD); Safety Biomarker (SAF): PIK3CA
Genes: PI3K
Study 35274472 — Predictive Biomarker (PRD): HIC1 mRNA
Genes: HIC1; ZBTB29
Study 35274472 — Predictive Biomarker (PRD): NADK2 mRNA
Genes: NADK2; C5orf33; MNADK; NADKD1
Study 35274704 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study 35274717 — Predictive Biomarker (PRD): BTC mRNA
Genes: BTC
Study 35274722 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study 35274722 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study 35276694 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 35276694 — Predictive Biomarker (PRD): ERBB3 mRNA
Genes: ERBB3; HER3
Study 35276694 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study 35276694 — Predictive Biomarker (PRD): SRC mRNA
Genes: SRC; SRC1
Study 35277389 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study 35277733 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 35278000 — Predictive Biomarker (PRD); Safety Biomarker (SAF): PIK3CA
Genes: PI3K
Study 35278000 — Predictive Biomarker (PRD): PIK3CA mRNA
Genes: PIK3CA
Study 35278825 — Predictive Biomarker (PRD): ALK tyrosine kinase receptor
Genes: ALK
Study 35278825 — Predictive Biomarker (PRD): ROS1 mRNA
Genes: ROS1; MCF3; ROS
Study 35278845 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study 35278845 — Predictive Biomarker (PRD): ALK tyrosine kinase receptor
Genes: ALK
Study 35278845 — Predictive Biomarker (PRD): ROS1
Genes: MCF3; ROS; c-ros-1
Study 35278845 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 35278845 — Predictive Biomarker (PRD): Proto-oncogene c-Met
Genes: MET
Study 35278845 — Predictive Biomarker (PRD): KRAS mRNA
Genes: KRAS; KRAS2; RASK2
Study 35279143 — Safety Biomarker (SAF): Cytochrome P450 2D6
Genes: CYP2D6; CYP2DL1
Study 35279143 — Safety Biomarker (SAF): Glucose-6-phosphate dehydrogenase
Genes: G6PD
Study 35279152 — Predictive Biomarker (PRD): MYC mRNA
Genes: MYC; BHLHE39
Study 35279152 — Predictive Biomarker (PRD): MAX mRNA
Genes: MAX; BHLHD4
Study 35280802 — Predictive Biomarker (PRD): SOX21 mRNA
Genes: SOX21; SOX25; SOXA
Study 35281074 — Safety Biomarker (SAF): miR-155
Genes: MIR155
Study 35281074 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 35282086 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study 35282136 — Predictive Biomarker (PRD): TPO mRNA
Genes: TPO
Study 35282383 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study 35283460 — Predictive Biomarker (PRD): Hormone receptor
Study 35283693 — Predictive Biomarker (PRD): Glutamate carboxypeptidase II
Genes: FOLH1; FOLH; NAALAD1; PSM; PSMA; GIG27
Study 35285015 — Predictive Biomarker (PRD): LOX mRNA
Genes: LOX
Study 35285015 — Predictive Biomarker (PRD): LOXL2 mRNA
Genes: LOXL2
Study 35285484 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study 35285786 — Predictive Biomarker (PRD): CCR5 mRNA
Genes: CCR5; CMKBR5
Study 35285859 — Surrogate Endpoint (SUR): Blood pressure
Study 35287171 — Predictive Biomarker (PRD): SLC5A2 mRNA
Genes: SLC5A2; SGLT2
Study 35287469 — Predictive Biomarker (PRD): Proto-oncogene c-Met
Genes: MET
Study 35287469 — Predictive Biomarker (PRD): AXL mRNA
Genes: AXL; UFO
Study 35287613 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 35287672 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study 35287722 — Predictive Biomarker (PRD): CD34 mRNA
Genes: CD34
Study 35287972 — Predictive Biomarker (PRD): PCSK9 mRNA
Genes: PCSK9; NARC1; PSEC0052
Study 35288462 — Predictive Biomarker (PRD): ZEB1 mRNA
Genes: ZEB1; AREB6; TCF8
Study 35288468 — Predictive Biomarker (PRD): JAK1 mRNA
Genes: JAK1; JAK1A; JAK1B
Study 35288468 — Predictive Biomarker (PRD): Indoleamine 2,3-dioxygenase 1
Genes: IDO1; IDO; INDO
Study 35289316 — Predictive Biomarker (PRD): IKBKG mRNA
Genes: IKBKG; FIP3; NEMO
Study 35289316 — Predictive Biomarker (PRD): TBK1 mRNA
Genes: TBK1; NAK